Shares of Evoke plc (LON:EVOK – Get Free Report) fell 10% during mid-day trading on Thursday . The company traded as low as GBX 50.20 ($0.65) and last traded at GBX 51.73 ($0.67). 65,066,164 shares were traded during trading, an increase of 1,994% from the average session volume of 3,107,171 shares. The stock had previously closed at GBX 57.45 ($0.74).
Wall Street Analyst Weigh In
A number of research analysts have recently weighed in on the company. Berenberg Bank dropped their target price on Evoke from GBX 130 ($1.68) to GBX 90 ($1.16) and set a “buy” rating on the stock in a report on Wednesday, December 4th. Jefferies Financial Group reiterated a “buy” rating and issued a GBX 140 ($1.81) target price on shares of Evoke in a research note on Monday, December 16th.
Check Out Our Latest Stock Report on EVOK
Evoke Price Performance
Evoke (LON:EVOK – Get Free Report) last issued its quarterly earnings results on Wednesday, March 26th. The company reported GBX (6.40) (($0.08)) earnings per share for the quarter. Evoke had a negative return on equity of 517.98% and a negative net margin of 8.50%. On average, research analysts forecast that Evoke plc will post 12.7648305 EPS for the current year.
Insider Buying and Selling at Evoke
In other news, insider Andrea Gisle Joosen acquired 14,572 shares of the stock in a transaction that occurred on Tuesday, January 28th. The shares were acquired at an average cost of GBX 70 ($0.91) per share, for a total transaction of £10,200.40 ($13,202.69). Corporate insiders own 27.00% of the company’s stock.
About Evoke
Further Reading
- Five stocks we like better than Evoke
- What Is WallStreetBets and What Stocks Are They Targeting?
- MarketBeat Week in Review – 03/24 – 03/28
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
- 3 Tickers Leading a Meme Stock Revival
- 4 Healthcare Stocks With Massive Gains—and More to Come
Receive News & Ratings for Evoke Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evoke and related companies with MarketBeat.com's FREE daily email newsletter.